Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product

Inclusion Criteria: * Written parents' informed consent to have their child participate in the study and attend the study procedures and processes as outlined in the protocol * Male or female babies/children aged between 1 month and 4 years * Mild AD presenting a maximum SCORAD of 25 (at Screening and Baseline) * Acute flare-up phase * Local SCORAD ≥ 5 on the target area (at Screening and Baseline) * Skin type I - IV according to Fitzpatrick Exclusion Criteria: * Any other skin disease at the target area that would interfere the clinical assessment in the opinion of the investigator * Known allergies to any of the ingredients of the IMPs * Any other adjuvant therapy for AD (UV therapy, probiotics, homeopathy etc.) within 30 days before Baseline as well as during the entire study * Any use of another topical emollient or other established treatment for AD during Phase 1 (cure phase) and Phase 2 (care phase) at the site of flares (AD lesions). Exception are usual hygienic products in the nappy area